(Q47819826)

English

Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice

scientific article published on 2 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Helga Westerlind

object named as

Helga Westerlind

5

1 reference

ORCID Public Data File 2021

author name string

Roger Jungedal

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Malin Lundkvist

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Elin Engdahl

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Ajith Sominanda

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Jan Hillert

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Anna Fogdell-Hahn

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

publication date

2 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

18

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

1775-1781

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Neutralizing antibodies against interferon β: fluctuation is modest and titre dependent

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assay

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Antibodies against interferon-beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

The clinical impact of interferon beta antibodies in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458512446036

21 January 2018

Identifiers

10.1177/1352458512446036

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22551640

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47819826&oldid=2172104810"